Welcome to kongre.net
Speaker
Chief Scientific Officer & Founder, Tagworks Pharmaceuticals BV
Marc Robillard, Chief Scientific Officer & Founder at Tagworks Pharmaceuticals BV, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Reimagining Antibody-Based Radiopharmaceuticals: Using Click-to-Release Technology to Expand the Therapeutic Window Across Multiple Targets”.
1–3 Dec 2026London, United Kingdom
Vice President CMC & Project Lead, OncoOne
Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics, UHN
Chief Executive Officer, OranoMed
Senior Expert - Strategic Therapeutic Innovation, Novartis
Director of Research, Brookline Capital Markets
Chief Technology Officer, Nuclide Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Marc Robillard, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].